Skip to main content

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

XENE holding history

Xenon Pharmaceuticals Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XENE overviewAll 13F holders of XENEFull Q2 2026 holdings

Shares (Q2 2026)
36,595
Value
$2.21M
% of portfolio
<0.1%
Quarters held
20
Since Q2 2021
Holdings of XENE by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202636,595$2.21M<0.1%+36,595NewHolders
Q1 20260$00.0%−452,147−100.0%Sold outHolders
Q4 2025452,147$20.3M<0.1%−1,876−0.4%ReducedHolders
Q3 2025454,023$18.2M<0.1%+74,035+19.5%AddedHolders
Q2 2025379,988$11.9M<0.1%+165,128+76.9%AddedHolders
Q1 2025214,860$7.21M<0.1%−45,110−17.4%ReducedHolders
Q4 2024259,970$10.2M<0.1%−39,895−13.3%ReducedHolders
Q3 2024299,865$11.8M<0.1%−136,595−31.3%ReducedHolders
Q2 2024436,460$17.0M<0.1%+26,253+6.4%AddedHolders
Q1 2024410,207$17.7M<0.1%+7,539+1.9%AddedHolders
Q4 2023402,668$18.5M<0.1%−24,457−5.7%ReducedHolders
Q3 2023427,125$14.6M<0.1%+165,018+63.0%AddedHolders
Q2 2023262,107$10.1M<0.1%+196,841+301.6%AddedHolders
Q1 202365,266$2.34M<0.1%−249,407−79.3%ReducedHolders
Q4 2022314,673$12.4M<0.1%−27,358−8.0%ReducedHolders
Q3 2022342,031$12.3M<0.1%+167,069+95.5%AddedHolders
Q2 2022174,962$5.32M<0.1%−118,767−40.4%ReducedHolders
Q1 2022293,729$8.98M<0.1%+1,783+0.6%AddedHolders
Q4 2021291,946$9.12M<0.1%+140,749+93.1%AddedHolders
Q3 2021151,197$2.31M<0.1%+136,187+907.3%AddedHolders
Q2 202115,010$279.0K<0.1%+15,010NewHolders